BRAWLEY OTIS W (CIK 1213029) reported 7 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-06-10). Recent activity: Buy INCY (1,642 shares), Buy A (2,158 shares), Buy A (888 shares), Buy INCY (2,518 shares), Buy LYEL (35,640 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-10 | INCYTE CORP (INCY) | Director | Buy | 1,642 | $0 |
| 2026-03-23 | AGILENT TECHNOLOGIES, INC. (A) | Director | Buy | 2,158 | $241,156 |
| 2026-03-23 | AGILENT TECHNOLOGIES, INC. (A) | Director | Buy | 888 | $99,234 |
| 2025-06-12 | INCYTE CORP (INCY) | Director | Buy | 2,518 | $0 |
| 2025-04-02 | Lyell Immunopharma, Inc. (LYEL) | Director | Buy | 35,640 | $0 |
| 2025-03-18 | AGILENT TECHNOLOGIES, INC. (A) | Director | Buy | 1,819 | $220,426 |
| 2025-03-18 | AGILENT TECHNOLOGIES, INC. (A) | Director | Buy | 812 | $98,398 |
Source: SEC Form 4 filings · as of 2026-06-10